112 related articles for article (PubMed ID: 21397297)
21. Effects of reagent and instrument on prothrombin times, activated partial thromboplastin times and patient/control ratios.
Naghibi F; Han Y; Dodds WJ; Lawrence CE
Thromb Haemost; 1988 Jun; 59(3):455-63. PubMed ID: 3187932
[TBL] [Abstract][Full Text] [Related]
22. Laboratory evaluation of the Coasys® Plus C coagulation analyzer.
de Bie P; Schornagel WJ; van den Dool EJ; Bakker B; van Dam W; Heckman M; Ağar C; Sturk A; Stroobants AK
Thromb Res; 2013 Apr; 131(4):357-62. PubMed ID: 23473640
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the automated coagulation analyzer Sysmex CA-7000.
Fischer F; Appert-Flory A; Jambou D; Toulon P
Thromb Res; 2006; 117(6):721-9. PubMed ID: 16098565
[TBL] [Abstract][Full Text] [Related]
24. Clinical evaluation of a microsample coagulation analyzer, and comparison with existing techniques.
Carter AJ; Hicks K; Heldman AW; Resar JR; Laird JR; Coombs VJ; Brinker JA; Blumenthal RS
Cathet Cardiovasc Diagn; 1996 Sep; 39(1):97-102. PubMed ID: 8874958
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of an automated hemostasis testing analyzer, the Trombolyzer Combi.
Ermens AA; Bury JG; Wijn-Maas EC
Clin Lab; 2000; 46(9-10):463-7. PubMed ID: 11034531
[TBL] [Abstract][Full Text] [Related]
26. The laboratory heterogeneity of lupus anticoagulants.
Triplett DA; Brandt JT; Maas RL
Arch Pathol Lab Med; 1985 Oct; 109(10):946-51. PubMed ID: 3929747
[TBL] [Abstract][Full Text] [Related]
27. Analytical Assessment of the New Roche Cobas t 711 Fully Automated Coagulation Analyzer.
Lippi G; Salvagno GL; Gelati M; Poli G; Giavarina D; Favaloro EJ
Semin Thromb Hemost; 2019 Apr; 45(3):308-314. PubMed ID: 30699441
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of prothrombin time and activated partial thromboplastin time mixing studies using an estimated factor correction method.
Chen J; Phillips B; Chandler WL
Blood Coagul Fibrinolysis; 2016 Jan; 27(1):90-6. PubMed ID: 26397883
[TBL] [Abstract][Full Text] [Related]
29. The effects of inaccurate blood sample volume on prothrombin time (PT) and activated partial thromboplastin time (aPTT).
Peterson P; Gottfried EL
Thromb Haemost; 1982 Apr; 47(2):101-3. PubMed ID: 7101228
[TBL] [Abstract][Full Text] [Related]
30. Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording.
Joist JH; Cowan JF; Khan M
J Lab Clin Med; 1977 Dec; 90(6):1054-65. PubMed ID: 303667
[TBL] [Abstract][Full Text] [Related]
31. [Mixing test for prolonged clotting time: clinical availability and problems].
Uchiba M; Ando Y
Rinsho Byori; 2009 Oct; 57(10):1004-12. PubMed ID: 19928499
[TBL] [Abstract][Full Text] [Related]
32. A comparison of INRs after local calibration of thromboplastin international sensitivity indexes.
McGlasson DL
Clin Lab Sci; 2002; 15(2):91-5. PubMed ID: 12776770
[TBL] [Abstract][Full Text] [Related]
33. Collection of blood specimens by venipuncture for plasma-based coagulation assays: necessity of a discard tube.
Raijmakers MT; Menting CH; Vader HL; van der Graaf F
Am J Clin Pathol; 2010 Feb; 133(2):331-5. PubMed ID: 20093244
[TBL] [Abstract][Full Text] [Related]
34. Standardization of coagulation tests.
Opartkiattikul N
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of an automated algorithm for interpretation of lupus anticoagulant testing.
Florin L; Desloovere M; Devreese KMJ
Int J Lab Hematol; 2019 Jun; 41(3):412-417. PubMed ID: 30860670
[TBL] [Abstract][Full Text] [Related]
36. Use of modified functional assays for activated protein C resistance in patients with basally prolonged aPTT.
Montaruli B; Schinco P; Pannocchia A; Giorgianni A; Borchiellini A; Tamponi G; Pileri A
Thromb Haemost; 1997 Sep; 78(3):1042-8. PubMed ID: 9308751
[TBL] [Abstract][Full Text] [Related]
37. Fluorescence-based blood coagulation assay device for measuring activated partial thromboplastin time.
Dudek MM; Kent N; Gustafsson KM; Lindahl TL; Killard AJ
Anal Chem; 2011 Jan; 83(1):319-28. PubMed ID: 21121686
[TBL] [Abstract][Full Text] [Related]
38. [Unsuspected prolonged activated partial thromboplastin time in emergency surgery. Diagnostic and therapeutic guide].
Barrio J; Peris V; Asensio I; Molina I; López F; García V
Rev Esp Anestesiol Reanim; 2002 Oct; 49(8):424-7. PubMed ID: 12455323
[TBL] [Abstract][Full Text] [Related]
39. [Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization].
Mischke R
Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):225-9. PubMed ID: 12058600
[TBL] [Abstract][Full Text] [Related]
40. A "percent correction" formula for evaluation of mixing studies.
Chang SH; Tillema V; Scherr D
Am J Clin Pathol; 2002 Jan; 117(1):62-73. PubMed ID: 11789732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
